Literature DB >> 21292260

In vitro fertilization outcomes in patients experiencing a premature rise in luteinizing hormone during a gonadotropin-releasing hormone antagonist cycle.

Nicole E Kummer1, Vanessa N Weitzman, Claudio A Benadiva, David W Schmidt, Lawrence L Engmann, John C Nulsen.   

Abstract

Patients undergoing controlled ovarian hyperstimulation and pituitary suppression with a GnRH antagonist who experienced a transient premature rise in LH were compared with those who did not have an early surge. Those experiencing a premature LH surge had equivalent clinical and ongoing pregnancy rates per ET.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21292260     DOI： 10.1016/j.fertnstert.2010.12.046

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  7 in total

1.  [Effects of cetrorelix versus ganirelix in gonadotropin-releasing hormone antagonist cycles for preventing premature luteinizing hormone surges and on clinical outcomes of IVF-ET cycles].

Authors:  Jun Zhang; Xingyu Zhou; Yingxue Chen; Qingyan Zhang; Ying Li; Jing Zhe; Xin Chen; Shiling Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

2.  Is there a Need for Luteinizing Hormone (LH) Estimation in Patients Undergoing Ovarian Stimulation with Gonadotropin-Releasing Hormone (GnRH) Antagonists and Recombinant Follicle-Stimulating Hormone (rFSH)?

Authors:  Amar Ramachandran; Kshitij Jamdade; Pratap Kumar; Satish Kumar Adiga; Rajeshwari G Bhat; Sinatra R Ferrao
Journal:  J Clin Diagn Res       Date:  2014-01-12

3.  Diminished Ovarian Reserve Predisposes to Premature Luteinizing Hormone Surges in Gonadotropin-Releasing Hormone Antagonist Cycles in In vitro Fertilization.

Authors:  Puneet Kaur Kochhar; Pranay Ghosh
Journal:  J Hum Reprod Sci       Date:  2020-10-27

4.  Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study.

Authors:  Yue Lin; Qianqian Chen; Jing Zhu; Yili Teng; Xuefeng Huang; Xia Chen
Journal:  Drug Des Devel Ther       Date:  2021-12-21       Impact factor: 4.162

5.  A Premature Rise of Luteinizing Hormone Is Associated With a Reduced Cumulative Live Birth Rate in Patients ≥37 Years Old Undergoing GnRH Antagonist In Vitro Fertilization Cycles.

Authors:  Fumei Gao; Yanbin Wang; Dan Wu; Min Fu; Qiuxiang Zhang; Yumeng Ren; Zexi Yang; Huan Shen; Hongjing Han
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-02       Impact factor: 5.555

6.  Does Serum LH Level Influence IVF Outcomes in Women with PCOS Undergoing GnRH-Antagonist Stimulation: A Novel Indicator.

Authors:  Jing Wang; Jinli Ding; Bing Qu; Yi Zhang; Qi Zhou
Journal:  J Clin Med       Date:  2022-08-11       Impact factor: 4.964

7.  The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF/ICSI treatments.

Authors:  Xiuxian Zhu; Hongjuan Ye; Yonglun Fu
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.